LFMD · LifeMD, Inc. · Proposed Sales
$1.45
-0.15 (-9.40%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$69.84M
Shares
48.33M
Volume · Nov 20
1.58M
Avg daily vol (3M)
922.28K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-03-23 | FRIEDEMAN JESSICA | Officer | 40,000 | 2026-03-23 | Charles Schwab & Co., Inc. |
| 2025-11-24 | FRIEDEMAN JESSICA | Officer | 20,000 | 2025-11-24 | Charles Schwab Corp |
| 2025-09-10 | Alvarez Nicholas P | Officer | 75,000 | 2025-09-10 | Charles Schwab Corp. |
| 2025-08-01 | Justin Schreiber | Chairman and CEO | 175,000 | 2025-08-01 | J.P. Morgan Securities LLC |
| 2025-06-13 | Stefan Galluppi | Affiliate | 85,000 | 2025-06-13 | J.P. Morgan Securities LLC |
| 2025-04-29 | Justin Schreiber | Chairman and CEO | 125,000 | 2025-04-29 | J.P. Morgan Securities LLC |
| 2024-12-02 | Justin Schreiber | CEO | 100,000 | 2024-12-02 | J.P. Morgan Securities LLC |
Showing 1–7 of 7 filings
Key facts
CIK
948320
CUSIP
53216B104
13F (30d)
100 filings
84 filers
Visit website
Investor relations